Target Women’s Clinics, Keep Recruitment Open To Get More Women Into Trials, FDA Says In Guidance
This article was originally published in The Gray Sheet
Executive Summary
FDA urges device firms to use a host of strategies to beef up enrollment of women in clinical trials to support device clearances and approvals, including targeting women’s clinics for recruitment efforts and revising enrollment criteria to include more females, in a final sex-specific clinical study guidance released Aug. 22.
You may also be interested in...
Products Lacking Good Subgroup Data Shouldn’t Be Approved, Patient, Medical Groups Tell FDA
FDA should more strongly enforce requirements for adequate demographic subgroup representation in clinical trials for devices and other medical products, participants said at an April 1 meeting on collection and analysis of clinical trial subpopulation data to support product registration.
Prestige Expands UK Eye Care Range In Response To Consumer Demand
A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.